1. SurgPath; Alimentary; Traumatic; Colon; solitary rectal ulcer syndrome
2. SurgPath; Soft Tissue; Neoplastic; Benign; desmoid-type fibromatosis
3. SurgPath; Nervous System; Neoplastic; pleomorphic xanthoastrocytoma
4. SurgPath; Soft Tissue; Infectious; Parasitic; trichinosis
5. SurgPath; Genital/Female; Neoplastic; Malignant; extramammary Paget's disease of the vulva
6. SurgPath; Endocrine; Metabolic/Physiologic/Congenital; Albright's syndrome
7. SurgPath; Hepato; hepatic microvesicular steatosis
8. SurgPath; Genital/Female; Neoplastic; Malignant; Burkitt's lymphoma
9. SurgPath; Genital/Male; Neoplastic; Malignant; Gleason grading of prostatic adenocarcinoma
10. SurgPath; Respiratory; Neoplastic; Malignant; IVBAT
11. SurgPath; Hepato; Metabolic/Physiologic/Congenital; liver biopsy
12. SurgPath; Mediastinal & Heart; Neoplastic; Malignant; thymic neoplasm
13. SurgPath; Breast; Neoplastic; Malignant; angiosarcoma of the breast
14. SurgPath; Hepato; focal nodular hyperplasia
15. SurgPath; Head & Neck; olfactory neuroblastoma
16. SurgPath; Breast; Neoplastic; Malignant; lobular carcinoma in situ
17. SurgPath; Respiratory; pulmonary small cell (oat-cell) carcinoma
18. SurgPath; Respiratory; Neoplastic; Malignant; lymphangitic carcinomatosis
19. SurgPath; Skin; Neoplastic; Malignant; immunoreactivity for CD31 and CD34
20. SurgPath; Genital/Female; Sertoli-Leydig cell tumor
21. SurgPath; Endocrine; Neoplastic; Malignant; papillary thyroid cancer
22. SurgPath; Soft Tissue; Neoplastic; Malignant; synovial sarcoma
23. SurgPath; Skin; Reactive/Immunologic/Degenerative; bullous pemphigoid
24. SurgPath; Reticuloendothelial; Reactive; Castleman's disease
25. SurgPath; Breast; Neoplastic; Malignant; medullary carcinoma of the breast
26. SurgPath; Genital/Male; spermatic cord tissue
27. SurgPath; Urinary Tract; Reactive/Immunologic/Degenerative; renal glomerulus / hepatitis B
28. SurgPath; Endocrine; Metabolic/Physiologic/Congenital; oat cell carcinoma / corticotropin-releasing factor
29. SurgPath; Skin; Reactive; erythema nodosum
30. SurgPath; Head & Neck; Neoplastic; Malignant; adenoid cystic carcinoma
31. SurgPath; Reticuloendothelial; Neoplastic; Malignant; lymphomatoid papulosis
32. SurgPath; Endocrine; Neoplastic; acinar cell carcinoma of the pancreas
33. SurgPath; Soft Tissue; Neoplastic; myxoma
34. SurgPath; Breast; Neoplastic; microglandular hyperplasia of the breast
35. SurgPath; Miscellaneous; Mikulicz cell
36. SurgPath; Alimentary; ulcerative colitis vs. Crohn's disease
37. SurgPath; Genital/Male; Neoplastic; Malignant
38. SurgPath; Nervous System; Infections; Fungal; CNS zygomycosis
39. SurgPath; Hepato; Metabolic/Physiologic/Congenital; Wilson's disease
40. SurgPath; Urinary Tract; Reactive/Immunologic; glomerulonephritis / epithelial crescents
41. SurgPath; Breast; HER-2/neu
42. SurgPath; Reticuloendothelial; Nodular Lymphocyte-Hodgkin's Disease; hematopoietic neoplasm
43. SurgPath; Hepato; Neoplastic; Mallory bodies
44. SurgPath; Alimentary; Barrett's esophagus; Barrett’s esophagus
45. SurgPath; Bone/Joint; osteochondroma
46. SurgPath; Head & Neck; repeated epistaxis and nasal obstruction
47. SurgPath; Bone/Joint; fibrous dysplasia
48. SurgPath; Urinary Tract; malakoplakia
49. SurgPath; Respiratory; diffuse alveolar damage
50. SurgPath; Mediastinal & Heart; aortic stenosis and systemic hypertension
51. SurgPath; Mediastinal & Heart; aortic lesion / fibrillin
52. SurgPath; Genital/Female; Neoplastic; Malignant; cervical biopsy / adenocarcinoma in situ
53. SurgPath; Genital/Female; Neoplastic; Benign; uterine contents / 46XX
54. SurgPath; Breast; Neoplastic; Benign; invasive ductal carcinoma
55. SurgPath; Alimentary; Infection; Parasitic; HIV / Giardia lamblia
56. SurgPath; Alimentary; Immunologic/Reactive; Menetrier's disease
57. SurgPath; Alimentary; Infectious; Parasitic; HIV / cryptosporidiosis
58. SurgPath; Nervous System; Infectious; Parasitic; AIDS / toxoplasmosis
59. SurgPath; Genital/Female; Infectious; Bacterial; prolonged rupture of membranes
60. SurgPath; Bone Joint; Reactive; subchondral avascular necrosis
1
61. SurgPath; Reticuloendothelial; Infectious; Mycobacterial; AIDS / AFB stain
62. SurgPath; Respiratory; Reactive/Immunologic; hemoptysis and active urine sediment / c-ANCA
63. SurgPath; Urinary Tract; Neoplastic; papillary renal cell; chromophil (papillary) renal cell carcinoma
64. SurgPath; Genital/Male; Neoplastic; adenomatoid tumor; intrascrotal mass
65. SurgPath; Soft Tissue; Neoplastic; granular cell tumor; tongue / Schwann cells
66. Cytopath; Female Genital Tract; HPV
67. Cytopath; Female Genital Tract; Malignant Disease; Metastatic Tumors; cervical cells / primary site
68. Cytopath; Respiratory System; Malignant; Adenocarcinoma; bronchoalveolar carcinoma
69. Cytopath; Body Cavity Fluids; Special Techniques; staining mesothelial cell
70. Cytopath; Body Cavity Fluids; Malignant; multiple myeloma
71. Cytopath; Female Genital Tract; Non-infectious; normal cervical
72. Cytopath; Urinary System; Benign disease; epithelial atypia mimicking cancer; false-positive diagnosis
73. Cytopath; Respiratory System; Malignant Disease; Metastatic tumors; site of origin / breast
74. Cytopath; Urinary System; Malignant; Low grade TCC; low-grade transitional cell carcinoma
75. Cytopath; Urinary System; Benign Disease; normal transitional epithelium
76. Cytopath; Alimentary System; Gastric Lymphoma; large cell lymphoma
77. Cytopath; Female Genital Tract; Malignant disease; malignant melanoma
78. Cytopath; Female Genital Tract; Specimen collection; cervical / unsatisfactory for evaluation
79. Cytopath; Body Cavity Fluids; HIV / malignant hematopoietic neoplasm
80. Cytopath; Female Genital Tract; AIS; vaginal smear
81. Cytopath; Female Genital Tract; HGSIL; vaginal smear
82. Cytopath; Urinary System; Urine Cytology; high-grade transitional cell carcinoma
83. Cytopath; Female Genital Tract; Benign/Reactive; cervical smear
84. Cytopath; Alimentary System; adenocarcinoma
85. Cytopath; Respiratory System; bronchoalveolar carcinoma
86. Cytopath; Fine Needle Aspiration; Malignant Disease; Liver; hepatocellular carcinoma
87. Cytopath; Fine Needle Aspiration; Metastatic Disease; Bone; prostate carcinoma
88. Cytopath; Respiratory System Benign disease; Non-infectious; reactive / reparative changes
89. Cytopath; Respiratory System; Specimen collection and preparation techniques; Saccomanno technique
90. Cytopath; Fine Needle Aspiration; Malignant diseases; Salivary glands; mucoepidermoid carcinoma
91. Cytopath; Fine Needle Aspiration; Malignant diseases; Liver; metastatic small cell carcinoma
92. Cytopath; Female Genital Tract; Dysplasia and in situ carcinoma; HGSIL
93. Cytopath; Female Genital Tract; Malignant disease; Endometrial; adenocarcinoma
94. Cytopath; Respiratory System; Malignant disease; Metastatic tumors; lung aspirate / parotid surgery
95. Cytopath; Body Cavity Fluids; Malignant diseases; Metastatic tumor; adenocarcinoma
96. Cytopath; Body Fluid; Malignant diseases; Metastatic Tumor; appendix
97. Cytopath; FNA; Malignant Disease; Thyroid; immunocytochemical stain
98. Cytopath; FNA; Malignant Disease; adrenal mass / staining for TTF 1
99. Cytopath; Female Genital Tract; Benign Disease; Non-infectious; lower uterine segment sampling
100. Cytopath; FNA; Malignant Disease; Lymph Nodes; follicle center lymphoma
101. Cytopath; FNA; Malignant Disease; Adrenal cortical carcinoma
102. Cytopath; Female Genital Tract; Benign disease; non-infectious; reactive / reparative changes
103. Cytopath; Alimentary System; Benign lesions; esophagus; herpes infection
104. Cytopath; Body Cavity Fluids; Benign disease; Mollaret's meningitis
105. Cytopath; Female Genital Tract; Benign Disease; Candida species infection
106. Cytopath; Female Genital Tract; Benign Disease; non-infectious; IUD
107. Forensic Path; Medicolegal Autopsy; Post Mortem Changes; fire artifact
108. Forensic Path; Post Mortem Chemistry; Endogenous Substances; urea nitrogen
109. Forensic Path; Post Mortem Chemistry; Toxicology; gas chromatography temperatures
110. Forensic Path; Legal Medicine; Courtroom Testimony; expert witness
111. Forensic Path; Post Mortem Chemistry; Toxicology; gastric injury / cyanide
112. Forensic Path; Cutting & Stabbing; wound characteristics
113. Forensic Path; Firearms; intermediate entrance wound
114. Forensic Path; Natural Death; polycystic renal disease
115. Forensic Path; Blunt Trauma; Traffic; overstretching due to impact
116. Forensic Path; Natural Death; Therapeutic Artifact; vasopressor therapy
117. Forensic Path; Cutting and Stabbing; Diagnosis; incised wound vs. laceration
118. Forensic Path; Post Mortem Chemistry; Toxicology; designer drugs
119. Forensic Path; Firearms; Shotguns; wound characteristics
120. Forensic Path; Miscellaneous; motor vehicle accident / atlantooccipital dislocation
2
121. Forensic Path; Post Mortem Chemistry; Endogenous Substances; vitreous fluid; hyperglycemia
122. Forensic Path; Medicolegal Autopsy; Techniques & Terminology; manual strangulation
123. Forensic Path; Firearms; Shotguns; noncontact shotgun wound
124. Forensic Path; Blunt Trauma; contusion
125. Forensic Path; Battered Child; lesions; intentional infliction
126. Forensic Path; Natural Death; arrythmogenic right ventricular cardiomyopathy
127. Forensic Path; Legal Medicine; identification of remains
128. Forensic Path; Blunt Trauma; epidural hematomas
129. Forensic Path; Blunt Trauma; laceration
130. Forensic Path; Firearms; Handguns; gunshot wound
131. Forensic Path; Blunt Trauma; Cranio Cerebral; brain
132. Forensic Path; Medicolegal Autopsy; Post Mortem Changes; larynx and proximal trachea
133. Forensic Path; Firearms; Handguns; flechette projectile
134. Chem; Technical Methods; Analytical Methods; Proteins; protein electrophoresis
135. Chem; Chemical Pathology; lactose testing interpretation
136. Chem; Technical Methods; Instrumentation; gas chromatographic separations
137. Chem; Technical Methods; Analytical Methods; intracellular cation
138. Chem; Technical Methods; Instrumentation; sandwich technique vs. competitive binding
139. Chem; Technical Methods; Instrumentation; batch analyzers
140. Chem; Technical Methods; Functional Tests; ACTH stimulation test
141. Chem; Technical Methods; Analytical Methods; arsenic poisoning
142. Chem; Technical Methods; Instrumentation; Electrophoresis; protein electrophoresis
143. Chem; Chemical Pathology; primary hyperthyroidism
144. Chem; Technical Methods; Analytical Methods; cocaine
145. Chem; Chemical Pathology; Immunization and Vaccinations; hypomagnesemia
146. Chem; Chemical Pathology; homocysteine in plasma
147. Chem; Chemical Pathology; intact PTH
148. Chem; Chemical Pathology; serum prealbumin
149. Chem; Chemical Pathology; marker of bone formation
150. Chem; Chemical Pathology; pseudogout
151. Chem; Chemical Pathology; Disorders of carbohydrate metabolism; hypokalemia and diabetic ketoacidosis
152. Chem; Technical Methods; Functional tests; Adrenal Corticol; serum sodium
153. Chem; Technical Methods; Specimen collection & processing; preanalytical variation
154. Chem; Chemical Pathology; Biochemistry of cancer; adrenal pheochromocytomas
155. Chem; Chemical Pathology; Biochemistry of cancer; Bence Jones proteinuria
156. Chem; Technical Methods; General Procedures; Electrophoresis;
157. Chem; Technical Methods; Special Specimens; Joint Fluid; grading of joint fluid
158. Chem; Technical Methods; Special Specimens; Spinal Fluid; xanthochromia
159. Chem; Chemical Pathology; Disorders of lipid metabolism; hypercholesterolemia
160. Chem; Chemical Pathology; Electrolyte and acid/base disorders; metabolic alkalosis
161. Chem; Technical Methods; Analytical methods by chemical group; Carbohydrates; glycohemoglobin
162. Chem; Chemical Pathology; Normal values; sarcoidosis
163. Chem; Technical Methods; Analytical methods by chemical group; Toxicology; methanol ingestion
164. Chem; Chemical Pathology; Diseases of skeletal muscle; markers of bone resorption
165. Chem; Chemical Pathology; Renal disease; calcitrol
166. Chem; Chemical Pathology; Electrolyte and acid/base disorders; salicylates
167. Chem; Quantitative Analysis of Results; Normal values; pregnancy
168. Chem; Chemical Pathology; Biochemistry of cancer; PSA and free PSA
169. Chem; Chemical Pathology; Cardiovascular disease; BNP
170. Chem; Chemical Pathology; Cardiovascular disease; Adult Treatment Panel
171. Chem; Quantitative Analysis of Results; Diagnostic sensitivity and specificity; observational study of risk
172. Chem; Technical Methods; Instrumentation; analytical sensitivity
173. Chem; Quantitative Analysis of Results; Statistical aspects of diagnosis; risk of developing disease
174. Chem; Technical Methods; General Procedures; Calculations & statistics; linear regression
175. Heme; Peripheral Blood; RBCs; hemoglobinopathy
176. Heme; Bone Marrow; aplastic crisis
177. Heme; Peripheral Blood; RBCs; microcytic hypochromic
178. Heme; Coagulation; endothelial cell protective mechanism
179. Heme; Coagulation; Disease states; adequate oral therapy
180. Heme; Bone Marrow; small cleaved cell lymphoma
3
181. Heme; Bone Marrow; thrombotic thrombocytopenic purpura
182. Heme; Bone marrow; Leukemias & PreLeukemic States; hairy cell
183. Heme; Bone Marrow; Leukemia; antecedent disease
184. Heme; Peripheral Blood; WBC; Leukemic States; prognosis / t(9;22)(q34; q11.2)
185. Heme; Peripheral Blood; WBC; Leukemic States; pancytopenia / CD19, 20, 11c and Slg
186. Heme; Peripheral Blood; Platelets; platelet satellitosis
187. Heme; Peripheral Blood; WBC's; Reactive States; persistent lymphocytosis
188. Heme; Bone Marrow; Leukemic & Pre Leukemic States; chronic myeloid leukemia
189. Heme; Bone Marrow; Reactive & Proliferative States; systemic mast cell disease
190. Heme; Peripheral Blood; RBC’s; multiple myeloma; Type 1 cryoglobulinemia
191. Heme; Coagulation; Platelets; Thrombocytopenia; drug-induced (other than heparin)
192. Heme; Coagulation; Platelets; Glanzmann thrombastenia
193. Heme; Laboratory Procedures; Specimen collection; karyotypic analysis
194. Heme; Laboratory Procedures & Special Techniques; cryopreservation
195. Heme; Lymph Nodes; Hodgkin's lymphoma; antigens
196. Heme; Lymph Nodes; mantle cell lymphoma
197. Heme; Lymph Nodes; large cell lymphoma / phenotype
198. Heme; Spleen; stain for presumptive diagnosis
199. Heme; WBC’s; Leukemic states; intravascular large cell lymphoma
200. Heme; Bone marrow; Plasma cells; plasma cell immunophenotype
201. Heme; Peripheral Blood; WBC’s; Leukemic states; B-cell prolymphocytic immunophenotype
202. Heme; Peripheral Blood; RBCs; Anemias Hemolytic (secondary cold antibody hemolytic anemia
203. Heme; Peripheral Blood; RBC’s; Anemias Hemolytic (secondary coccemia
204. Heme; Peripheral Blood; WBC’s; Leukemic States; cytogenetic abnormalities
205. Heme; Laboratory Procedures & Techniques; Instrumentation; chromogenic assays
206. Heme; Peripheral Blood; WBC's; Leukemic States; chronic lymphocytic immunophenotype
207. Heme; Peripheral Blood; RBC's; Anemias/Hemoglobinapathies & thalassemias; hemoglobin E trait
208. Heme; Coagulation; Disease States; Factor Deficiencies; acquired inhibiter to Factor Viii
209. Heme; Peripheral Blood; WBC's; Leukemic States; trisomy 21
210. Heme; Peripheral Blood; RBC’s; newborn screen
211. Heme; Coagulation; Disease States; Factor Deficiencies; von Willebrand's disease type 2
212. Heme; Coagulation; Platelets; Other; platelet glycoprotein IIb/IIIa
213. Heme; Coagulation; Disease States; prothrombin G20210A mutation
214. Heme; Laboratory Procedures & Techniques; Special Techniques; monitor of new anticoagulants
215. Micro; Bacteriology; Non-fermentative gram negative; Pseudomonas; cystic fibrosis
216. Micro; Mycology; Systemic mycoses; Blastomycosis;
217. Micro; Antimicrobial Therapy; Mechanisms of action/resistance; Bacteroides resistance;
218. Micro; Mycology; Systemic mycoses; Coccidiomycosis; characteristics
219. Micro; Bacteriology; Gram-Positive cocci; Staphylococci;
220. Micro; Bacteriology; Non-fermentive Gram-Negative Bacilli; Flavobacterium;
221. Micro; Parasitology; Helminths; Strongyloides; renal transplant patient
222. Micro; Chlamydiae, Rickettsia, and Viruses; Chlamydiae; Chlamydia;
223. Micro; Mycology; Yeast; candidemia; iritis
224. Micro; Antimicrobial Therapy; enterococcal susceptibility testing
225. Micro; Bacteriology; Salmonella 0642:J6
226. Micro; Clinical Micro; Cryptosporidium
227. Micro; Clinical Micro; Specimen collection; blood culture
228. Micro; Clinical Micro; Opportunistic Mycoses;
229. Micro; Bacteriology; Mycobacteria; HIV
230. Micro; Clinical Micro; Major Clinical Syndromes; Lower Respiratory Tract; Streptococcus pneumoniae
231. Micro; Parasitology; protozoa; Babesia
232. Micro; Bacteriology; Mycobacterium xenopi
233. Micro; Antimicrobial Therapy; Susceptibility Testing; Klebsiella pneumoniae
234. Micro; Bacteriology; Staphylococcus; small colony variant
235. Micro; Bacteriology; Fermenter; gram-negative bacillus; swarms
236. Micro; Bacteriology; Gram-negative bacillus; blood culture; multilobar pneumonia
237. Micro; General Clinical Micro; heat labile toxin
238. Micro; Bacteriology; Gram-negative cocci; Brucella melitensis
239. Micro; Bacteriology; Enterobacteriaceae; Hirudo medicinalis
240. Micro; Bacteriology; Enterobacteriaceae; E. coli
4
241. Micro; Viruses; Picornaviridae; coxsackie A virus
242. Micro; Clinical Micro; yellow fever
243. Micro; Antimicrobial Therapy; Mechanisms of action/resistance; Beta-lactamase S. aureus / mecA gene
244. Micro; Bacteriology; fastidious gram-negative bacilli; Francisella tularensis
245. Micro; Clinical Micro; Major clinical syndromes; Skin and soft tissue; Pseudomonas aeruginosa
246. Micro; Bacteriology; Gram-positive cocci; Staphylococci;
247. Micro; Parasitology; Protozoa; Leishmania; Kala-azar
248. Micro; Viruses; Papovaviridae; HPV-18
249. Micro; Parasitology; Protozoa; Plasmodium vivax
250. Micro; Bacteriology; Gram-positive cocci; Enterococci; indwelling urinary catheter
251. Micro; Antimicrobial Therapy; Susceptibility testing; Disc diffusion, Broth dilution; Streptococcus pneumoniae
252. Micro; Bacteriology; Anaerobic bacteria; Gram-positive bacilli; cytotoxin A and B
253. Micro; Viruses; Adenoviridae; acute myelogenous leukemia with neutropenic fever
254. Micro; Mycology; Systemic mycoses; Histoplasmosis;
255. Trans Med; Paternity Testing/Genetics; HLA phenotypes
256. Trans Med; Transfusion Practices; hypovolemic / crystalloid solution vs. FFP
257. Trans Med; Lab Administration, Inspection and Accreditation; AABB Standards; volunteer donors
258. Trans Med; Transfusion Transmitted Disease; CMV negative; third generation, filtered blood cells
259. Trans Med; Transfusion Practices; Platelet transfusion; refractory / HLA-A and HLA-B
260. Trans Med; Prenatal and Perinatal Transfusion Medicine; neonate transfusion
261. Trans Med; Prenatal and Perinatal Transfusion Medicine; anti-Le(a); immune mediated hemolysis
262. Trans Med; Prenatal and Perinatal Transfusion Medicine; neonatal alloimmune thrombocytopenia
263. Trans Med; Transfusion Practices; Component Storage; biochemical changes
264. Trans Med; Antibody Reactions & Identification; immediate spin crossmatch
265. Trans Med; Antibody Reactions & Identification; Immunization and Vaccinations; delayed transfusion reactions
266. Trans Med; Antibody Reactions & Identification; DIC
267. Trans Med; Antibody Reactions & Identification; delayed transfusion reactions
268. Trans Med; Transfusion Transmitted Disease; hepatitis C
269. Trans Med; Transfusion Transmitted Disease; decrease in non-A, non-B hepatitis transmission
270. Trans Med; Antibody Reactions & Identification; Compatibility testing; AABB Standards;
271. Trans Med; Transfusion Practices; Selection of Blood;
272. Trans Med; Prenatal and Perinatal Transfusion Medicine; calculate RhIG
273. Trans Med; Blood Group System; Rh genotypes
274. Trans Med; Antibody Reactions & Identification; paroxymal nocturnal hemoglobinuria
275. Trans Med; Transfusion Practices; plasma derivatives
276. Trans Med; Lab Administration; Emergency Blood Release; Standards; 50-60% total blood volume loss
277. Trans Med; Transfusion Transmitted Disease; Transfusion Reactions; TRALI;
278. Trans Med; Transfusion Practices; intravenous anti-D / idiopathic thrombocytopenic purpura
279. Trans Med; Transfusion Transmitted Disease; TRALI; HLA or neutrophil antibody
280. Trans Med; Transfusion Transmitted Disease; graft vs. host disease; prevention
281. Trans Med; Miscellaneous; thrombocytopenic purpura; treatment options
282. Trans Med; Transfusion Practices; RhoGam indications
283. Trans Med; Transfusion Practices; Component Storage; plasma
284. Trans Med; Lab Administration; Cryoprecipitate; AABB Standards; FVIII and fibrinogen
285. Trans Med; Transfusion Practices; hemophilia A; hemostatic agents
286. Trans Med; Lab Administration, Inspection and Accreditation; FDA; transfusion-related fatalities
287. Trans Med; Paternity Testing/Genetics; phenotypes
288. Trans Med; Donor Requirements; reduction of HBV transmission risk; strategies
289. Trans Med; Donor Requirements; AABB standards
290. Trans Med; Donor Requirements; autologous vs. volunteer donors
291. Trans Med; Transfusion Practices; component; administration
292. Trans Med; Donor Requirements; apheresis donation reaction
293. Trans Med; Transfusion Practices; Apheresis; hematopoietic progenitor cell graft; components for transfusion
294. Trans Med; Transfusion Practices; umbilical cord blood vs. peripheral hematopoietic progenitor cells
295. Immunopathology; Autoantibodies; Disease States; Renal Diseases; membranous glomerulonephritis
296. Immunopathology; Autoantibodies; Disease States; Endocrine Diseases; Hashimoto's thyroiditis
297. Immunopathology; Cellular Immunology; Infectious Mononucleosis, anti-VCA (IgG)
298. Immunopathology; Protein Disorders; Lab Procedures & Technique; late neurosyphillis
299. Immunopathology; Autoantibodies; Disease States; Neurologic Diseases; myasthenia gravis
300. Immunopathology; Cellular Immunology; Disease States; Disease Associated w/ HLA; narcolepsy
5
301. Immunopathology; Cellular Immunology; Disease States; selective IgA deficiency
302. Immunopathology; Cellular Immunology; Immunoproliferative Diseases; anti-bcl-2 protein antibody
303. Immunopathology; Cellular Immunology; Disease State; Lymphokines; cytokines
304. Immunopathology; Protein Disorders; Disease State; Immunodeficiencies; disseminated Neisseria meningitidis
305. Immunopathology; Cellular Immunology; Disease States; Immunodeficiencies; ataxia telaniectasia
306. Immunopathology; Cellular Immunology; Lab Procedures & Technique; T lymphocytes; CD3
307. Immunopathology; Autoantibodies; neonatal lupus
308. Immunopathology; Autoantibodies; Type 1 hereditary angioedema
309. Immunopathology; Protein Disorders; Lab Procedures & Technique; Type III cryoglobulin
310. Immunopathology; Autoantibodies; Lab Procedures & Technique; p-ANCA
311. Immunopathology; FISH; chronic lymphocytic leukemia
312. Lab Admin; Personnel; style
313. Lab Admin; Personnel; Motivation; McGregor's Theory X-Theory Y;
314. Lab Admin; Marketing; Customer Relations; customerization of healthcare;
315. Lab Admin; Personnel; future success;
316. Lab Admin; Personnel; Performance Standards/Evaluations; defense against wrongful termination lawsuits
317. Lab Admin; Personnel; certification of lab employees
318. Lab Admin; Accreditation, Licensure, Regulation; CLIA 88
319. Lab Admin; General Management Theory; Maslow
320. Lab Admin; General Management Theory; customer satisfaction
321. Lab Admin; Accreditation, Licensure, Regulation; JCAHO and CAP
322. Lab Admin; Operations; Quality Assurance; Appropriate Use of Tests; sensitivity and specificity
323. Lab Admin; Financial; Reimbursement Issues; Ambulatory Payment Classification
324. Lab Admin; Operations; Interdepartmental Relations; medical staff committees
325. Lab Admin; Operations; Safety; Right-to-know
326. Lab Admin; Financial; Reimbursement Issues; i.e., Medicare, Public Aid, HMO's, PPO's; DRG
327. Lab Admin; Operations; Safety; symbols
328. Lab Admin; Operations; Medical-Legal Issues Specifics; negligence
329. Special Techniques; Flow Cytometry; angle scatter
330. Special Techniques; Image Analysis; DNA Analysis; Stain Techniques; image analysis
331. Special Techniques; Molecular Pathology; Tumor Suppressor Genes; p53
332. Special Techniques; Molecular Pathology; antisense probe with denaturation; mRNA + DNA
333. Special Techniques; Molecular Pathology; Gene Rearrangements; mantle cell lymphoma
334. Special Techniques; Flow cytometry; Immunophenotyping; mantle cell lymphoma
335. Special Techniques; Flow Cytometry; Polymerase Chain Reaction; reducing amplicon contamination
336. Special Techniques; Flow Cytometry; Polymerase Chain Reaction; chronic lymphocytic leukemia
337. Special Techniques; Molecular Pathology; TRAP assay
338. Special Techniques; Molecular Pathology; Polymerase Chain Reaction; false-negative; Hepatitis C
6